tetano
Editor, Senior Moderator
Ann Med Surg (Lond)
. 2021 Nov;71:103028.
doi: 10.1016/j.amsu.2021.103028. Epub 2021 Nov 5.
Aseptic meningoencephalitis after COVID-19 vaccination: A case report
Shwan A Ahmad[SUP] 1 [/SUP], Bestoon Kh Salih[SUP] 1 [/SUP], Karokh F Hama Hussein[SUP] 1 [/SUP], Tomas M Mikael[SUP] 1 2 [/SUP], Fahmi H Kakamad[SUP] 1 3 2 [/SUP], Abdulwahid M Salih[SUP] 1 3 [/SUP]
Affiliations
Abstract
Introduction: Several types of vaccine have been shown to significantly reduce the risk of severe coronavirus disease 2019 (COVID-19). This study aims to report the first case of meningoencephalitis after receiving the second dose of Pfizer COVID-19 vaccine.
Case report: A 62-year-old lady presented with headache, fever and rigor for 4 days. She had acute confessional state and inability to talk. She was conscious, disoriented, not obeying commands. Acyclovir vial IV 750 mg three times a day for 14 days were prescribed. She responded very well.
Discussion: Concern has been raised about the safety of vaccinations. The most common side effects of COVID-19 vaccinations are local responses at the injection site, followed by non-specific systemic symptoms such as headache, tiredness, myalgia, and fever. These may appear shortly after immunization and disappear in a short period of time.
Conclusion: Although extremely rare, aseptic meningoencephalitis could occur after COVID-19 vaccination. The patient could be managed conservatively with a good clinical outcome.
Keywords: Aseptic; COVID-19; Meningoencephalitis.
. 2021 Nov;71:103028.
doi: 10.1016/j.amsu.2021.103028. Epub 2021 Nov 5.
Aseptic meningoencephalitis after COVID-19 vaccination: A case report
Shwan A Ahmad[SUP] 1 [/SUP], Bestoon Kh Salih[SUP] 1 [/SUP], Karokh F Hama Hussein[SUP] 1 [/SUP], Tomas M Mikael[SUP] 1 2 [/SUP], Fahmi H Kakamad[SUP] 1 3 2 [/SUP], Abdulwahid M Salih[SUP] 1 3 [/SUP]
Affiliations
- PMID: 34777795
- PMCID: PMC8570436
- DOI: 10.1016/j.amsu.2021.103028
Abstract
Introduction: Several types of vaccine have been shown to significantly reduce the risk of severe coronavirus disease 2019 (COVID-19). This study aims to report the first case of meningoencephalitis after receiving the second dose of Pfizer COVID-19 vaccine.
Case report: A 62-year-old lady presented with headache, fever and rigor for 4 days. She had acute confessional state and inability to talk. She was conscious, disoriented, not obeying commands. Acyclovir vial IV 750 mg three times a day for 14 days were prescribed. She responded very well.
Discussion: Concern has been raised about the safety of vaccinations. The most common side effects of COVID-19 vaccinations are local responses at the injection site, followed by non-specific systemic symptoms such as headache, tiredness, myalgia, and fever. These may appear shortly after immunization and disappear in a short period of time.
Conclusion: Although extremely rare, aseptic meningoencephalitis could occur after COVID-19 vaccination. The patient could be managed conservatively with a good clinical outcome.
Keywords: Aseptic; COVID-19; Meningoencephalitis.